格隆汇9月15日丨澳洋健康(002172.SZ)公布，公司控股股东澳洋集团与张家港悦升科技合伙企业（有限 合伙）（简称"悦升科技"）签署了《股份转让协议》，澳洋集团拟将其持有的公司20%股份共计 153,146,472股，以协议转让方式转让给悦升科技。本次股份转让价格为3.87元/股，股份转让的交易价 款合计为人民币592,676,846.64元。本次协议转让完成后，澳洋集团和沈学如先生不再是公司控股股东 及实际控制人，公司控股股东将变更为悦升科技，张家港经济技术开发区管委会将成为公司实际控制 人。公司股票自2025年9月16日（星期二）上午开市起复牌。 ...

财务顾问 东吴证券股份有限公司 关于 江苏澳洋健康产业股份有限公司 详式权益变动报告书 之 财务顾问核查意见 一、本财务顾问依据的有关资料由信息披露义务人提供。信息披露义务人 已向本财务顾问作出承诺，保证其所提供的一切信息包括书面材料、文件或口 头证言资料等均具有真实性、准确性、完整性和及时性。 二、本财务顾问已按照规定履行了尽职调查义务，对信息披露义务人披露 的《江苏澳洋健康产业股份有限公司详式权益变动报告书》进行了核查，确信 披露文件内容与格式符合规定，并有充分理由确信所发表的专业意见与信息披 露义务人披露的文件内容不存在实质性差异。 三、本财务顾问特别提醒投资者注意，本财务顾问核查意见不构成对本次 权益变动相关各方及其关联公司的任何投资建议，投资者根据本财务顾问核查 意见所做出的任何投资决策而产生的相应风险，本财务顾问不承担任何责任。 四、本财务顾问就《江苏澳洋健康产业股份有限公司详式权益变动报告书》 所发表的核查意见是独立进行的，未委托或授权任何其他机构或个人提供未在 本财务顾问核查意见中列载的信息和对本核查意见做任何解释或者说明。 五、本财务顾问特别提醒本次交易相关主体及投资者认真阅读信息披露义 务 ...

Market Strategy - The market continues to experience a shrinking volume oscillation, with trading volume dropping to 2 trillion yuan [4][7] - The overall A-share market saw a slight increase, with the Wind All A Index rising by 0.22% to 6092.31 points, while the Shanghai Composite Index rose by 0.13% to 3812.22 points [7][8] - The innovation growth sector performed well, with the ChiNext Index increasing by 1.27% to 2904.27 points, while the North China 50 Index saw a slight decline of 0.16% [7][8] Economic Indicators - In August, the Producer Price Index (PPI) decreased by 2.9% year-on-year, an improvement from the previous month's decline of 3.6% [17][18] - The Consumer Price Index (CPI) also fell by 0.4% year-on-year in August, remaining flat month-on-month [19][20] - The central bank conducted a 7-day reverse repurchase operation amounting to 304 billion yuan, with a fixed interest rate of 1.40% [21][22] Industry Dynamics - The company "Mingming Hen Mang" has surpassed 20,000 stores nationwide, solidifying its position as a leading player in the leisure food and beverage retail sector [27][28] - Hengtai Securities has officially changed its name to Financial Street Securities, marking its entry into the state-owned securities sector [29][30] - The world's largest floating wind turbine foundation, with a capacity of 16MW, has been completed and delivered, representing a significant milestone in offshore wind energy projects [31][32] - In the first half of 2025, China's wind turbine market saw new orders totaling 80GW, with onshore wind turbine orders reaching 73GW, reflecting a year-on-year growth of 6% [33][34] Company Updates - Aoyang Health (002172.SZ) is currently suspended from trading as it plans to transfer its shares, which may lead to changes in its controlling shareholder [36][37] - Baile Tianheng (688506.SH) has had its drug "iza-bren" included in the list of breakthrough therapy designations for certain cancer patients [38][39] - Linyang Energy (601222.SH) has won a bid for the first batch of metering equipment for the Southern Power Grid, with a contract value of approximately 244.08 million yuan [40][41] - Zoomlion (000157.SZ) has successfully delivered its first boom crane from its German factory, marking a significant step in its localization strategy in Europe [43][44] - Xianhui Technology (688155.SH) has signed an agreement to establish a joint laboratory for advanced solid-state battery technology, aiming to accelerate the industrialization of solid-state batteries [46][47] Regional Economic Dynamics - Electric Broad Media (000917.SZ) has completed the issuance of its first phase of medium-term notes, raising 300 million yuan with a maturity of three years and a coupon rate of 2.18% [48]

Group 1 - Aoyang Group is planning to transfer the controlling stake of its listed company Aoyang Health, which may lead to a change in actual control [1][4] - Aoyang Group was established in 1998 and has over 30 subsidiaries and more than 5,000 employees, focusing on health, green ecology, and textile industries [3][4] - The company has undergone significant transformations, including the sale of its viscose business to a leading industry player and a shift towards the health industry [4][5] Group 2 - Aoyang Health's stock was suspended from trading starting September 9, with an expected suspension period of no more than two trading days [1] - The identity of the potential buyer for Aoyang Health's controlling stake remains uncertain, with speculation about possible related parties [6] - Aoyang Group has previously reduced its stake in Aoyang Shunchang, now known as Weilan Lithium, through multiple transactions, leading to a decrease in its controlling position [5]

Group 1 - Tianpu Co., Ltd. experienced a significant stock price increase of 185.29% from August 22 to September 10, leading to a halt for further investigation due to abnormal trading [4] - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure [5] - Qingshan Paper Industry confirmed that its production and operational activities are normal, with no significant changes in daily operations [6] Group 2 - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer by its controlling shareholder [7] - ST Jinke will implement a capital reserve transfer to increase share capital, resulting in a one-day stock suspension [8] - ST Haofeng's stock will resume trading on September 11 after a share transfer agreement was signed, making Zhixin Network the controlling shareholder [9] Group 3 - Fushun Special Steel's stock will be suspended for one day due to a tender offer for shares by Ningbo Meishan Free Trade Port Zone Jincheng Shazhou Equity Investment Co., Ltd. [10] - Fuliwang's subsidiary plans to invest 500 million yuan in a high-end wire material research and production project [11] - ST Tianmao's application for voluntary delisting has been accepted by the Shenzhen Stock Exchange [12] Group 4 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of Qinhuai Data China [13] - Betta Pharmaceuticals intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [14] - Longzi Co., Ltd. plans to acquire a 67.5% stake in Chongqing Time for approximately 92.475 million yuan [15] Group 5 - Dongfang Guoxin plans to establish a joint venture for a technology company with Shunyi Jin Kong [16] - ST Lianshi signed a pre-restructuring investment agreement with selected investors [18] - Shaanxi Construction Group won four construction projects worth over 5 billion yuan in August [19] Group 6 - Dema Technology won a smart logistics project with a well-known Latin American e-commerce giant, valued at approximately 290 million yuan [20] - Mongolian Grass Ecology's subsidiary led a consortium to win a 225 million yuan ecological restoration project [21] - Dajin Heavy Industry signed a long-term production agreement for offshore wind power foundations, with a total value of about 1.25 billion yuan [24] Group 7 - Zhendong Medical's controlling shareholder plans to transfer 5% of the company's shares [25] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [26] - BYD's senior management and core personnel collectively increased their holdings by approximately 52.33 million yuan [27] Group 8 - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% [28] - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% [30] - Lanke Technology's shareholders plan to reduce their holdings by up to 2% [31]

Core Viewpoint - Aoyang Health (stock code: 002172) announced that its stock will continue to be suspended from trading starting September 11, 2025, with an expected suspension period of no more than three trading days [1] Company Summary - Aoyang Health's stock will remain suspended from trading for a maximum of three trading days [1]

Regulatory Actions - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws [3] - ST Haofeng announced that Zhixin Network will become the controlling shareholder after a share transfer agreement, with shares resuming trading on September 11, 2025 [7] - Fushun Special Steel will suspend trading for one day due to a share buyback offer, with a total of 9.865 million shares being offered at a price of 5.6 yuan per share [8] Operational Updates - Qingshan Paper Industry reported that its production and operational activities are normal, with no significant changes in daily operations [4] - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer, with an expected suspension period of no more than three trading days [5] - ST Jinke will implement a capital reserve transfer to increase share capital, leading to a one-day trading suspension [6] Major Contracts and Projects - Shaanxi Construction Group won four construction projects each exceeding 500 million yuan in August, including a 2.4 billion yuan project for a solar hydrogen production facility [11] - Demar Technology secured a 2.9 billion yuan contract for an intelligent logistics project with a well-known e-commerce giant in Latin America [13] - Mongolian Grass Ecology's subsidiary led a consortium that won a 2.25 billion yuan project for ecological protection and restoration in Inner Mongolia [14] - Sanfeng Environment signed a contract worth approximately 2.6 billion Macanese Patacas for waste management services in Macau, with a contract duration of 10 years [15] Shareholding Changes - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% through market transactions [17] - Sichuan Road and Bridge's controlling shareholder intends to reduce its stake by up to 2% through block trades [18] - Hexing Co., Ltd. announced that its controlling shareholder plans to reduce its stake by up to 3% through various trading methods [19] - Jingfang Technology's shareholder terminated its share reduction plan without executing any sales during the period [20]

Group 1 - The core point of the article is that Aoyang Health (002172.SZ) is in active negotiations regarding an overall transaction plan, but has not yet signed a formal agreement [1] - The company anticipates that it will not be able to resume trading on September 11, 2025, at the market opening [1] - Aoyang Health has applied to the Shenzhen Stock Exchange for an extension of its stock suspension, which is expected to last no more than three trading days [1]

Group 1 - The core point of the article is that Aoyang Health (002172.SZ) is in active negotiations regarding an overall transaction plan, but has not yet signed a formal agreement [1] - The company anticipates that it will not be able to resume trading on September 11, 2025, at the market opening [1] - Aoyang Health has applied to the Shenzhen Stock Exchange for an extension of its stock suspension, which is expected to last no more than three trading days [1]

Group 1 - The core point of the article is that Aoyang Health (002172.SZ) announced that its controlling shareholder, Aoyang Group, is planning to transfer shares, which may lead to a change in the controlling shareholder and actual controller of the company [1] - The company’s stock was suspended from trading on September 9, 2025, due to this announcement [1] - As of the announcement date, the parties involved are actively negotiating the overall transaction plan, but no formal agreement has been signed yet [1] Group 2 - The company anticipates that it will not be able to resume trading on September 11, 2025, and the stock will continue to be suspended [1] - The expected suspension period is not more than three trading days [1]